InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Hunder Naomi, Directeur Médical. Insider active across 1 companies, notably Silverback Therapeutics, Inc.. Aggregated, 3 disclosures have been published. The latest transaction was filed on 2 May 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations3 total
043,177 shares0
Common Stock
SEC:0001209191-22-027153:0·
011,250 shares0
Common Stock
SEC:0001209191-22-006436·
011,250 shares0
Common Stock
SEC:0001209191-22-006436:0·
3 of 3 declarations
About Hunder Naomi
Hunder Naomi serves as Chief Medical Officer for Silverback Therapeutics, Inc. In this role, she oversees the company's medical initiatives and research programs. Her expertise in medicine and biotechnology is essential for developing innovative treatments. Hunder is committed to improving patient health through advanced therapeutic solutions.
